LMH STRATEGIC SOLUTIONS

Lobbying for RARE DISEASE COMPANY COALITION · The Rare Disease Company Coalition

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income · posted Apr 18, 2025

Lobbying activity 1

Health Issues

Issues will be pediatric review vouchers. Orphan drug tax credit.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.